A carregar...
Bimatoprost Implant: First Approval
Bimatoprost implant (Durysta™), developed by Allergan, is a sustained-release drug delivery system containing bimatoprost, a prostaglandin analogue with ocular hypotensive activity. The implant, administered intracamerally, involves the use of a biodegradable, solid polymer drug delivery system for...
Na minha lista:
| Publicado no: | Drugs Aging |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7303088/ https://ncbi.nlm.nih.gov/pubmed/32447639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-020-00769-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|